Skip to content
Recall Observatory FDA recall evidence

Drug product

Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046, India, NDC 68180-723-04

D-0496-2024

April 24, 2024

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 94492
Status
Terminated
Classification
Class II
Quantity
17,070 bottles
Official record key
drug-enforcement:D-0496-2024

Official wording

Reason: Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.

Code information: Lot # F305442, Exp 8/30/2025

Distribution pattern: USA nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    foreign substance